Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-064771
Date:2021-11-12
Issuer: AEGLEA BIOTHERAPEUTICS, INC. (AGLE)
Original Submission Date:

Reporting Person:

SMITH HUNTER C
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN, TX 78746

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY) 7.04 2021-11-12 deemed execution date A 60,000 (a) 2031-11-11 common stock 60,000 $7.04 60,000 direct
Footnotes
IDfootnote
f1 the stock option vests and becomes exercisable in 36 equal monthly installments beginning on december 12, 2021 until such time as the option is 100% vested, subject to the continuing service of the reporting person on each vesting date.

Elevate your investments